PMAM
TLSIW icon

Picton Mahoney Asset Management’s TriSalus Life Sciences Warrant TLSIW Stock Holding History

Picton Mahoney Asset Management’s Portfolio TLSIW Stock Details TLSIW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-74,999
Closed -$76K – 949
2021
Q2 		$76K Buy
+74,999
New +$74K ﹤0.01% 721

Other funds holding TLSIW

RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
AGC
Angelo Gordon & Co New York $1.06B AUM 47.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
SCC
Spring Creek Capital Wichita, Kansas $2.53B AUM 19.59% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

Picton Mahoney Asset Management's TLSIW Position: Q3 2021 in Review

Picton Mahoney Asset Management sold out of TriSalus Life Sciences Warrant (TLSIW) in Q3 2021, closing a stake of 74,999 shares — an estimated $76K sold.

Picton Mahoney Asset Management first reported a position in TLSIW in Q2 2021 and held it in 1 quarter. The position peaked at $76K in Q2 2021. 25 funds tracked by Wall St. Rank hold TLSIW as of Q3 2021.

  • Picton Mahoney Asset Management reported no remaining TriSalus Life Sciences Warrant position as of Q3 2021 after selling out during the quarter.
  • Picton Mahoney Asset Management sold 74,999 TriSalus Life Sciences Warrant shares in Q3 2021, an estimated $76K.
  • Picton Mahoney Asset Management first reported a position in TriSalus Life Sciences Warrant in Q2 2021 and held it in 1 quarter.
  • Picton Mahoney Asset Management's TriSalus Life Sciences Warrant position peaked at $76K in Q2 2021.
  • 25 funds tracked by Wall St. Rank held TriSalus Life Sciences Warrant as of Q3 2021.

Based on Picton Mahoney Asset Management's 13F filing for Q3 2021, filed 9 Nov 2021.